WASHINGTON — The Generic Pharmaceutical Association on Monday hired Felecia (Lisa) Tan for the role of AVP sciences and regulatory affairs. Tan, a former practicing pharmacist, brings more than 25 yeas of healthcare and FDA experience to GPhA.
“We are delighted that Lisa Tan has joined the GPhA staff. Her hiring demonstrates our continued commitment to making collaboration with FDA a key priority,” said Ralph G. Neas, GPhA president and CEO. “Lisa’s private sector background and her extensive experience at FDA, particularly in the Office of Pharmaceutical Sciences and the Office of Generic Drugs, will help make the generic drug industry an even stronger partner with FDA in the future. Lisa’s mastery of the abbreviated new drug approval regulatory framework will be invaluable in the association’s efforts to work with FDA to enhance the ANDA process and support the full application of the Generic Drug User Fee Act.”
At the FDA Center for Drug Evaluation and Research's OPS and OGD, Tan was responsible for streamlining processes and protocols, receiving multiple awards for her operations leadership and technical expertise. Prior to her time at the FDA, Tan held several pharmacy management position. She received a pharmacy degree from the Massachusetts College of Pharmacy.